|
|
Blood, 15 June 2006, Vol. 107, No. 12, pp. 4807-4816.
Prepublished online as a Blood First Edition Paper on February 16, 2006; DOI 10.1182/blood-2005-11-4334.
Previous Article | Next Article 
Submitted November 3, 2005
Accepted February 6, 2006
Cell surface CD74 initiates a signaling cascade leading to cell proliferation and survival
Diana Starlets, Yael Gore, Inbal Binsky, Michal Haran, Nurit Harpaz, Lev Shvidel, Shirly Becker-Herman, Alain Berrebi, and Idit Shachar*
Department of Immunology, Weizmann Institute of Science, Rehovot, Israel
Hematology Institute, Kaplan Medical Center, Rehovot, Israel
* Corresponding author; email: idit.shachar{at}weizmann.ac.il.
CD74 is an integral membrane protein that was thought to function mainly as an MHC class II chaperone. However, recently CD74 was shown to have a role as an accessory signaling molecule. Our studies demonstrated that CD74 regulates B cell differentiation by inducing a pathway leading to the activation of transcription mediated by the NF- B p65/RelA homodimer and its coactivator, TAFII105. Here we show that CD74 stimulation with anti-CD74 antibody leads to an induction of a signaling cascade resulting in NF- B activation, entry of the stimulated cells into the S phase, elevation of DNA synthesis, cell division, and augmented expression of BCL-XL. These studies therefore demonstrate that surface CD74 functions as a survival receptor.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. L. Martin-Ventura, J. Madrigal-Matute, B. Munoz-Garcia, L. M. Blanco-Colio, M. Van Oostrom, G. Zalba, A. Fortuno, C. Gomez-Guerrero, L. Ortega, A. Ortiz, et al.
Increased CD74 expression in human atherosclerotic plaques: contribution to inflammatory responses in vascular cells
Cardiovasc Res,
August 1, 2009;
83(3):
586 - 594.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Leth-Larsen, R. Lund, H. V. Hansen, A.-V. Laenkholm, D. Tarin, O. N. Jensen, and H. J. Ditzel
Metastasis-related Plasma Membrane Proteins of Human Breast Cancer Cells Identified by Comparative Quantitative Mass Spectrometry
Mol. Cell. Proteomics,
June 1, 2009;
8(6):
1436 - 1449.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Stein, M. R. Smith, S. Chen, M. Zalath, and D. M. Goldenberg
Combining Milatuzumab with Bortezomib, Doxorubicin, or Dexamethasone Improves Responses in Multiple Myeloma Cell Lines
Clin. Cancer Res.,
April 15, 2009;
15(8):
2808 - 2817.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Marsh, L. Cakarova, G. Kwapiszewska, W. von Wulffen, S. Herold, W. Seeger, and J. Lohmeyer
Surface expression of CD74 by type II alveolar epithelial cells: a potential mechanism for macrophage migration inhibitory factor-induced epithelial repair
Am J Physiol Lung Cell Mol Physiol,
March 1, 2009;
296(3):
L442 - L452.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-H. Liu, C.-Y. Lin, W.-C. Lin, S.-W. Tang, M.-K. Lai, and J.-Y. Lin
Up-Regulation of Vascular Endothelial Growth Factor-D Expression in Clear Cell Renal Cell Carcinoma by CD74: A Critical Role in Cancer Cell Tumorigenesis
J. Immunol.,
November 1, 2008;
181(9):
6584 - 6594.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Kamir, S. Zierow, L. Leng, Y. Cho, Y. Diaz, J. Griffith, C. McDonald, M. Merk, R. A. Mitchell, J. Trent, et al.
A Leishmania Ortholog of Macrophage Migration Inhibitory Factor Modulates Host Macrophage Responses
J. Immunol.,
June 15, 2008;
180(12):
8250 - 8261.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Holst, M. R. Sorensen, C. M. Mandrup Jensen, C. Orskov, A. R. Thomsen, and J. P. Christensen
MHC Class II-Associated Invariant Chain Linkage of Antigen Dramatically Improves Cell-Mediated Immunity Induced by Adenovirus Vaccines
J. Immunol.,
March 1, 2008;
180(5):
3339 - 3346.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. C. Attar, D. J. DeAngelo, J. G. Supko, F. D'Amato, D. Zahrieh, A. Sirulnik, M. Wadleigh, K. K. Ballen, S. McAfee, K. B. Miller, et al.
Phase I and Pharmacokinetic Study of Bortezomib in Combination with Idarubicin and Cytarabine in Patients with Acute Myelogenous Leukemia
Clin. Cancer Res.,
March 1, 2008;
14(5):
1446 - 1454.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Gore, D. Starlets, N. Maharshak, S. Becker-Herman, U. Kaneyuki, L. Leng, R. Bucala, and I. Shachar
Macrophage Migration Inhibitory Factor Induces B Cell Survival by Activation of a CD74-CD44 Receptor Complex
J. Biol. Chem.,
February 1, 2008;
283(5):
2784 - 2792.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Huang, D. T. Cai, R. Y. R. Chua, D. M. Kemeny, and S. H. Wong
Nitric-oxide Synthase 2 Interacts with CD74 and Inhibits Its Cleavage by Caspase during Dendritic Cell Development
J. Biol. Chem.,
January 18, 2008;
283(3):
1713 - 1722.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Muller, D. Viemann, M. Schmidt, N. Endres, S. Ludwig, M. Leverkus, J. Roth, and M. Goebeler
Candida albicans Triggers Activation of Distinct Signaling Pathways to Establish a Proinflammatory Gene Expression Program in Primary Human Endothelial Cells
J. Immunol.,
December 15, 2007;
179(12):
8435 - 8445.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Lantner, D. Starlets, Y. Gore, L. Flaishon, A. Yamit-Hezi, R. Dikstein, L. Leng, R. Bucala, Y. Machluf, M. Oren, et al.
CD74 induces TAp63 expression leading to B-cell survival
Blood,
December 15, 2007;
110(13):
4303 - 4311.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Stein, M. J. Mattes, T. M. Cardillo, H. J. Hansen, C.-H. Chang, J. Burton, S. Govindan, and D. M. Goldenberg
CD74: A New Candidate Target for the Immunotherapy of B-Cell Neoplasms
Clin. Cancer Res.,
September 15, 2007;
13(18):
5556s - 5563s.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Binsky, M. Haran, D. Starlets, Y. Gore, F. Lantner, N. Harpaz, L. Leng, D. M. Goldenberg, L. Shvidel, A. Berrebi, et al.
IL-8 secreted in a macrophage migration-inhibitory factor- and CD74-dependent manner regulates B cell chronic lymphocytic leukemia survival
PNAS,
August 14, 2007;
104(33):
13408 - 13413.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. L. Meyer-Siegler, K. A. Iczkowski, L. Leng, R. Bucala, and P. L. Vera
Inhibition of Macrophage Migration Inhibitory Factor or Its Receptor (CD74) Attenuates Growth and Invasion of DU-145 Prostate Cancer Cells
J. Immunol.,
December 15, 2006;
177(12):
8730 - 8739.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|